PubRank

Hitoshi Katai

Author PubWeight™ 84.22‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol 2011 6.53
2 Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry. Gastric Cancer 2006 3.06
3 Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer. Nat Genet 2008 2.89
4 Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry. Gastric Cancer 2011 2.18
5 Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry. Gastric Cancer 2012 2.09
6 Endoscopic evaluation of the remnant stomach after gastrectomy: proposal for a new classification. Gastric Cancer 2002 2.01
7 Changing trends in the proportion of adenocarcinoma of the esophagogastric junction in a large tertiary referral center in Japan. J Gastroenterol Hepatol 2008 1.93
8 Impact of expression of human epidermal growth factor receptors EGFR and ERBB2 on survival in stage II/III gastric cancer. Clin Cancer Res 2012 1.74
9 Treatment of early gastric cancer in the elderly patient: results of EMR and gastrectomy at a national referral center in Japan. Gastrointest Endosc 2005 1.60
10 Pancreaticoduodenectomy for advanced gastric cancer. Gastric Cancer 2005 1.53
11 Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer. J Gastroenterol 2009 1.34
12 Recurrence in early gastric cancer with lymph node metastasis. Gastric Cancer 2009 1.33
13 Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer. J Surg Oncol 2007 1.33
14 Optimal extent of lymph node dissection for Siewert type II esophagogastric junction carcinoma. Ann Surg 2011 1.28
15 Identification of prognostic biomarkers in gastric cancer using endoscopic biopsy samples. Cancer Sci 2008 1.23
16 A phase III study of laparoscopy-assisted versus open distal gastrectomy with nodal dissection for clinical stage IA/IB gastric Cancer (JCOG0912). Jpn J Clin Oncol 2012 1.20
17 Influence of overweight on surgical complications for gastric cancer: results from a randomized control trial comparing D2 and extended para-aortic D3 lymphadenectomy (JCOG9501). Ann Surg Oncol 2006 1.19
18 Krüppel-like factor 12 plays a significant role in poorly differentiated gastric cancer progression. Int J Cancer 2009 1.18
19 Phase II study of preoperative chemotherapy with S-1 and cisplatin followed by gastrectomy for clinically resectable type 4 and large type 3 gastric cancers (JCOG0210). J Surg Oncol 2013 1.18
20 A functional single nucleotide polymorphism in mucin 1, at chromosome 1q22, determines susceptibility to diffuse-type gastric cancer. Gastroenterology 2010 1.17
21 Randomized Controlled Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma. Ann Surg 2017 1.16
22 Afferent loop obstruction after distal gastrectomy with Roux-en-Y reconstruction. World J Surg 2010 1.13
23 Follow-up of gastric cancer: a review. Gastric Cancer 2006 1.10
24 TNM and Japanese staging systems for gastric cancer: how do they coexist? Gastric Cancer 2004 1.09
25 Should adenocarcinoma of the esophagogastric junction be classified as esophageal cancer? Limited to Siewert type II, yes. Ann Surg 2015 1.09
26 E-cadherin gene variants in gastric cancer families whose probands are diagnosed with diffuse gastric cancer. Int J Cancer 2002 1.09
27 Billroth 1 versus Roux-en-Y reconstructions: a quality-of-life survey at 5 years. Int J Clin Oncol 2007 1.07
28 Phase II trial of S-1 for neoadjuvant chemotherapy against scirrhous gastric cancer (JCOG 0002). Gastric Cancer 2009 1.06
29 Present and future status of gastric cancer surgery. Jpn J Clin Oncol 2011 1.05
30 Gallstone formation after gastric cancer surgery. J Gastrointest Surg 2009 1.03
31 Multicenter study evaluating the clinical performance of the OSNA assay for the molecular detection of lymph node metastases in gastric cancer patients. Gastric Cancer 2013 0.99
32 Large-scale investigation into dumping syndrome after gastrectomy for gastric cancer. J Am Coll Surg 2010 0.98
33 Impact of the expression of thymidylate synthase and dihydropyrimidine dehydrogenase genes on survival in stage II/III gastric cancer. Gastric Cancer 2014 0.96
34 Neuroendocrine carcinoma of the stomach: morphologic and immunohistochemical characteristics and prognosis. Am J Surg Pathol 2013 0.96
35 Decreasing complication rates with stapled esophagojejunostomy following a learning curve. Gastric Cancer 2000 0.95
36 Integrated analysis of cancer-related pathways affected by genetic and epigenetic alterations in gastric cancer. Gastric Cancer 2014 0.95
37 Laparoscopy-assisted pylorus-preserving gastrectomy: a matched case-control study. Surg Endosc 2010 0.94
38 Systemic inflammatory response in gastric cancer. World J Surg 2010 0.94
39 Significance of lavage cytology in advanced gastric cancer patients. World J Surg 2010 0.94
40 Management of adjuvant S-1 therapy after curative resection of gastric cancer: dose reduction and treatment schedule modification. Gastric Cancer 2011 0.93
41 Increasing body mass index in Japanese patients with gastric cancer. Gastric Cancer 2005 0.93
42 Identification of risk factors for esophagojejunal anastomotic leakage after gastric surgery. World J Surg 2012 0.93
43 High-grade dysplasia associated with fundic gland polyposis in a familial adenomatous polyposis patient, with special reference to APC mutation profiles. Mod Pathol 2004 0.92
44 A case of lymph node metastasis following a curative endoscopic submucosal dissection of an early gastric cancer. Gastric Cancer 2011 0.92
45 Comprehensive DNA methylation and extensive mutation analyses reveal an association between the CpG island methylator phenotype and oncogenic mutations in gastric cancers. Cancer Lett 2012 0.91
46 A case of local recurrence and distant metastasis following curative endoscopic submucosal dissection of early gastric cancer. Gastric Cancer 2014 0.90
47 Comparison of HER2 status between surgically resected specimens and matched biopsy specimens of gastric intestinal-type adenocarcinoma. Virchows Arch 2014 0.90
48 Localized gastric amyloidosis differentiated histologically from scirrhous gastric cancer using endoscopic mucosal resection: a case report. J Med Case Rep 2012 0.89
49 Clinical impact of a strategy involving endoscopic submucosal dissection for early gastric cancer: determining the optimal pathway. Gastric Cancer 2011 0.89
50 Metachronous liver metastasis from early gastric cancer. J Gastrointest Surg 2011 0.88
51 HER2 expression in locally advanced gastric cancer with extensive lymph node (bulky N2 or paraaortic) metastasis (JCOG1005-A trial). Gastric Cancer 2014 0.86
52 Phase II study of laparoscopy-assisted distal gastrectomy with nodal dissection for clinical stage I gastric cancer: Japan Clinical Oncology Group Study JCOG0703. Jpn J Clin Oncol 2008 0.85
53 Adjuvant therapy with imatinib mesylate after resection of primary high-risk gastrointestinal stromal tumors in Japanese patients. Int J Clin Oncol 2011 0.85
54 Short-term outcomes of Roux-en-Y stapled anastomosis after distal gastrectomy for gastric adenocarcinoma. J Gastrointest Surg 2009 0.85
55 Stenosis of esophago-jejuno anastomosis after gastric surgery. World J Surg 2010 0.85
56 Overexpression of leucine-rich repeat-containing G protein-coupled receptor 5 in gastric cancer. Pathol Int 2012 0.84
57 Clinical significance of a papillary adenocarcinoma component in early gastric cancer: a single-center retrospective analysis of 628 surgically resected early gastric cancers. J Gastroenterol 2014 0.84
58 Gene expression network analysis of ETV1 reveals KCTD10 as a novel prognostic biomarker in gastrointestinal stromal tumor. PLoS One 2013 0.83
59 Dehiscence following successful endoscopic closure of gastric perforation during endoscopic submucosal dissection. World J Gastroenterol 2012 0.82
60 Hereditary diffuse gastric cancer in a Japanese family with a large deletion involving CDH1. Gastric Cancer 2013 0.82
61 Pfetin as a prognostic biomarker for gastrointestinal stromal tumor: validation study in multiple clinical facilities. Jpn J Clin Oncol 2011 0.82
62 Clinical proteomics identified ATP-dependent RNA helicase DDX39 as a novel biomarker to predict poor prognosis of patients with gastrointestinal stromal tumor. J Proteomics 2011 0.81
63 Survival analysis of adjuvant chemotherapy with S-1 plus cisplatin for stage III gastric cancer. Gastric Cancer 2013 0.81
64 Intraperitoneal delivery of a small interfering RNA targeting NEDD1 prolongs the survival of scirrhous gastric cancer model mice. Cancer Sci 2012 0.81
65 Small undifferentiated intramucosal gastric cancer with lymph-node metastasis: case report. World J Gastroenterol 2013 0.80
66 Bone metastasis from early gastric cancer following non-curative endoscopic submucosal dissection. World J Gastroenterol 2013 0.80
67 The genomic damage estimated by arbitrarily primed PCR DNA fingerprinting is useful for the prognosis of gastric cancer. Gastroenterology 2003 0.79
68 Surgical treatment of non-early gastric remnant carcinoma developing after distal gastrectomy for gastric cancer. J Surg Oncol 2014 0.79
69 Correlation between the length of the pyloric cuff and postoperative evaluation after pylorus-preserving gastrectomy. Gastric Cancer 2010 0.79
70 Pfetin as a prognostic biomarker in gastrointestinal stromal tumor: novel monoclonal antibody and external validation study in multiple clinical facilities. Jpn J Clin Oncol 2009 0.79
71 The prognostic significance of isolated tumor cells in the lymph nodes of gastric cancer patients. Gastric Cancer 2010 0.79
72 Causation of Borrmann type 4 gastric cancer: heritable factors or environmental factors? Gastric Cancer 2003 0.78
73 A case of long-term survival after surgical resection of solitary pulmonary metastasis from gastric cancer. Jpn J Clin Oncol 2009 0.78
74 Validation study on pfetin and ATP-dependent RNA helicase DDX39 as prognostic biomarkers in gastrointestinal stromal tumour. Jpn J Clin Oncol 2012 0.78
75 Identification of a DNA methylation marker that detects the presence of lymph node metastases of gastric cancers. Oncol Lett 2012 0.77
76 Clinical significance of molecular detection of matrix metalloproteinase-1 in bone marrow and peripheral blood in patients with gastric cancer. Ann Surg Oncol 2011 0.77
77 Prognostic significance of promyelocytic leukemia expression in gastrointestinal stromal tumor; integrated proteomic and transcriptomic analysis. Cancer Sci 2014 0.76
78 Consistent absence of HER2 expression, regardless of HER2 amplification status, in neuroendocrine carcinomas of the stomach. Histopathology 2014 0.76
79 Trends in characteristics of surgically treated early gastric cancer patients after the introduction of gastric cancer treatment guidelines in Japan. Gastric Cancer 2010 0.76
80 Distribution of the deepest penetrating point of minute submucosal gastric cancer. Jpn J Clin Oncol 2005 0.76
81 Incidence of pulmonary thromboembolism in gastric cancer surgery using routine thromboprophylaxis. Gastric Cancer 2010 0.75
82 Adult-onset inflammatory myofibroblastic tumour of the stomach with a TFG-ROS1 fusion. Histopathology 2014 0.75
83 Erratum to: Impact of the expression of thymidylate synthase and dihydropyrimidine dehydrogenase genes on survival in stage II/III gastric cancer. Gastric Cancer 2015 0.75
84 A rare case of poorly differentiated endocrine cell carcinoma of the stomach with signet ring cell differentiation. Gastric Cancer 2010 0.75
85 [Adjuvant chemotherapy using S-1 for curatively resected gastric cancer-the nationwide clinical trial]. Gan To Kagaku Ryoho 2006 0.75
86 [Tumors of upper digestive tract]. Nihon Rinsho 2010 0.75